Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1196
| Despition | Insulin Receptor beta Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1341 | Pax2 Blocking Peptide (AC1341) | 250 µg | inquiry |
| ACPP-1267 | Acrp30 Mouse, Trimeric (AC1267) | 2 µg | inquiry |
| ACPP-1461 | Human Luteinizing Hormone Protein (AC1461) | 100 µg | inquiry |
| ACPP-1351 | Dopamine D2 Receptor Blocking Peptide (AC1351) | 250 µg | inquiry |
| ACPP-1600 | Mouse IL 6 Protein, Sf9 (AC1600) | 2 µg | inquiry |
| ACPP-1352 | Myocilin Blocking Peptide (AC1352) | 250 µg | inquiry |
| ACPP-1270 | Luteinizing Hormone Blocking Peptide (AC1270) | 250 µg | inquiry |
| ACPP-1622 | Human DLK1 Protein (AC1622) | 2 µg | inquiry |
| ACPP-1060 | Recombinant Human ADAM17 Protein (Fc Tag) (AC1060) | 50 µg | inquiry |
| ACPP-1209 | CaMKII gamma Blocking Peptide (AC1209) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.